Anti-inhibitor coagulant complex (Autoplex) in hemophilia inhibitor patients undergoing synovectomy.
Surgical synovectomy employed in the management of hemophilic arthropathy has been contraindicated in patients with inhibitors because of potential difficulties in achieving hemostasis. However, the development of activated prothrombin-complex concentrates has improved the management of hemophiliacs with inhibitors, particularly those with high levels of inhibitor for whom other treatment modalities are of minimal benefit. With the use of one of these activated products, Autoplex, surgical procedures have been successfully accomplished in hemophiliacs with inhibitors. Two inhibitor patients who each had severe arthropathy of one knee underwent elective surgical synovectomy while being treated with Autoplex. Hemostasis was achieved during the perioperative period in both patients. Neither patient exhibited clinical signs of suggestive of consumptive coagulopathy or thrombosis, side effects potentially associated with the use of activated prothrombin-complex concentrates.
D000293:Adolescent; D001780:Blood Coagulation Tests; D002648:Child; D005164:Factor IX / Q000627:therapeutic use*; D015949:Factor IXa; D006395:Hemarthrosis / Q000601:surgery*; D006467:Hemophilia A / Q000150:complications*; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D007717:Knee / Q000601:surgery*; D008297:Male; D000074402:Synovectomy
D006490:Hemostatics; D005164:Factor IX; D015949:Factor IXa